Floatz logo

Rapamycin

Retinoblastoma

Emory UniversityPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Retinoblastoma cohort.

Asset / SponsorPhaseRating
FILGRASTIM
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4BBB
Itraconazole
Samsung Medical Center
Phase 4BB
Thiotepa
Masonic Cancer Center, University of Minnesota
Phase 2BB
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2BB
Cyclophosphamide
Seattle Children's Hospital
Phase 2BB

View all 28 →

Same molecule, other indications

Rapamycin is also rated in:

tuberous sclerosisDormant
BBB
Indicative ·
73 / 100
View asset →
disease related to transplantationDormant
BBB
Indicative ·
72 / 100
View asset →
myelodysplastic/myeloproliferative neoplasmDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →